Esperion Therapeutics, Inc. (0IIM.L)
USD 2.27
(-8.85%)
USD 2.27
(-8.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -135.48 Million | -174.82 Million | -263.8 Million | -85.17 Million | -70.34 Million | -148.63 Million |
| Net Income | -209.24 Million | -233.65 Million | -269.1 Million | -143.55 Million | -97.16 Million | -201.81 Million |
| Depreciation & Amortization | 164 Thousand | 500 Thousand | 612 Thousand | 547 Thousand | 319 Thousand | 265 Thousand |
| Deferred income taxes | 36.5 Million | - | -2.63 Million | -97 Thousand | -200 Thousand | - |
| Stock-based compensation | 11.4 Million | 15.21 Million | 24.3 Million | 28.38 Million | 25.88 Million | 23.96 Million |
| Change in working capital | 13.67 Million | -3.37 Million | -52.51 Million | -4.26 Million | -7.29 Million | 29.15 Million |
| Other non-cash items | 11.45 Million | 46.49 Million | 35.52 Million | 33.8 Million | 8.12 Million | -217 Thousand |
| Investing Cash Flow | 42.5 Million | 8.1 Million | -50.48 Million | 21.35 Million | 64.23 Million | 140.44 Million |
| Investments in PPE | - | - | - | -13.36 Million | -953 Thousand | -151 Thousand |
| Acquisitions | - | - | - | 12.5 Million | -65.18 Million | - |
| Investment purchases | - | -59.89 Million | -50.48 Million | -4.42 Million | -34.32 Million | -25.48 Million |
| Sales/Maturities of investments | 42.5 Million | 68 Million | - | 39.14 Million | 99.51 Million | 166.08 Million |
| Other Investing Activities | 42.5 Million | 8.1 Million | -50.48 Million | -12.5 Million | 65.18 Million | 140.6 Million |
| Financing Cash Flow | 50.46 Million | 32.6 Million | 268.22 Million | 201.72 Million | 136.19 Million | 10.69 Million |
| Debt repayment | -15.5 Million | -58.24 Million | -755 Thousand | -296.09 Million | -124.42 Million | -1.04 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -55 Million | - | - |
| Common Stock Issuance | 65.96 Million | 90.84 Million | 218.68 Million | 6.63 Million | 11.77 Million | 11.74 Million |
| Other Financing Activities | 1.00 | -50.21 Million | 50.29 Million | 848.91 Million | 248.84 Million | 11.74 Million |
| Accounts receivables | -14.76 Million | -10.79 Million | -10.54 Million | -10.74 Million | - | - |
| Accounts payables | 8.67 Million | 5.6 Million | -34.09 Million | 23.1 Million | -16.05 Million | 24.44 Million |
| Inventory | -30.42 Million | -807 Thousand | -18.25 Million | -16.13 Million | - | - |
| Other working capital | 50.18 Million | 2.62 Million | 10.39 Million | -490 Thousand | 8.75 Million | 4.71 Million |
| Cash at beginning of period | 124.77 Million | 258.89 Million | 304.96 Million | 167.05 Million | 36.97 Million | 34.46 Million |
| Cash at end of period | 82.24 Million | 124.77 Million | 258.89 Million | 304.96 Million | 167.05 Million | 36.97 Million |
| Capital Expenditure | - | - | - | -13.36 Million | -953 Thousand | -151 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -42.52 Million | -134.11 Million | -46.07 Million | 137.9 Million | 130.08 Million | 2.5 Million |
| Free Cash Flow | -135.48 Million | -174.82 Million | -263.8 Million | -98.54 Million | -71.29 Million | -148.78 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -61.92 Million | 61.02 Million | -56.34 Million | -209.24 Million | -41.25 Million | -49.93 Million |
| Depreciation & Amortization | 10 Thousand | 437 Thousand | 6000.00 | 164 Thousand | 26 Thousand | 51 Thousand |
| Deferred income taxes | - | - | -17.48 Million | 36.5 Million | - | -73 Thousand |
| Stock-based compensation | 2.93 Million | 3.23 Million | 2.92 Million | 11.95 Million | 2.97 Million | 3.16 Million |
| Change in working capital | -4.99 Million | -21.8 Million | 3.95 Million | 13.67 Million | 6.57 Million | 10.16 Million |
| Other non-cash items | 56.77 Million | 11.37 Million | 29.89 Million | 11.45 Million | 12.34 Million | 11.88 Million |
| Investing Cash Flow | -77 Thousand | -73 Thousand | - | 42.5 Million | - | 17.5 Million |
| Investments in PPE | -77 Thousand | -73 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 42.5 Million | - | 17.5 Million |
| Other Investing Activities | - | - | -42.5 Million | 42.5 Million | - | 17.5 Million |
| Financing Cash Flow | -30.02 Million | 90.6 Million | 4.47 Million | 50.46 Million | -4.31 Million | 809 Thousand |
| Debt repayment | -39.09 Million | -5.83 Million | -4.59 Million | -15.5 Million | -4.29 Million | -3.51 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -343.75 Million | - | 20 Thousand | - | -20 Thousand | - |
| Common Stock Issuance | 9.07 Million | 90.67 Million | 9.06 Million | 65.96 Million | -52.45 Million | 4.3 Million |
| Other Financing Activities | -30.02 Million | -66 Thousand | 4.47 Million | 1.00 | 52.43 Million | 10 Thousand |
| Accounts receivables | -5.74 Million | -6.11 Million | -5.87 Million | -14.76 Million | -1.82 Million | -4.38 Million |
| Accounts payables | 19.34 Million | -3.45 Million | 5.5 Million | 8.67 Million | 1.65 Million | 7.49 Million |
| Inventory | -11.37 Million | -7.47 Million | -14.18 Million | -30.42 Million | -5.75 Million | -6.32 Million |
| Other working capital | -7.22 Million | -4.76 Million | 18.51 Million | 50.18 Million | 12.5 Million | 13.37 Million |
| Cash at beginning of period | 226.6 Million | 82.24 Million | 114.83 Million | 124.77 Million | 138.47 Million | 144.91 Million |
| Cash at end of period | 189.3 Million | 226.6 Million | 82.24 Million | 82.24 Million | 114.83 Million | 138.47 Million |
| Capital Expenditure | -77 Thousand | -73 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -37.3 Million | 144.36 Million | -32.58 Million | -42.52 Million | -23.63 Million | -6.44 Million |
| Free Cash Flow | -7.28 Million | 53.75 Million | -37.05 Million | -135.48 Million | -19.32 Million | -24.75 Million |
2370
JGHG
0QQN
VIRI
BRKA
0KGB